A double-blind, randomized parallel-group, efficacy and safety study of intramuscular S-adenosyl-L-methionine 1,4-butanedisulphonate (SAMe) versus imipramine in patients with major depressive disorder

Paolo Pancheri; Pierluigi Scapicchio; Roberto Delle Chiaie

doi:10.1017/s1461145702003085

A double-blind, randomized parallel-group, efficacy and safety study of intramuscular S-adenosyl-L-methionine 1,4-butanedisulphonate (SAMe) versus imipramine in patients with major depressive disorder

The International Journal of Neuropsychopharmacology ◽

10.1017/s1461145702003085 ◽

2002 ◽

Vol 5 (4) ◽

pp. 287-294 ◽

Cited By ~ 32

Author(s):

Paolo Pancheri ◽

Pierluigi Scapicchio ◽

Roberto Delle Chiaie

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Efficacy And Safety ◽

Major Depressive ◽

Safety Study ◽

Double Blind ◽

Group Efficacy ◽

Parallel Group

Download Full-text

A Double-Blind Efficacy and Safety Study of Duloxetine Fixed Doses in Children and Adolescents with Major Depressive Disorder

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2013.0096 ◽

2014 ◽

Vol 24 (4) ◽

pp. 170-179 ◽

Cited By ~ 43

Author(s):

Graham J. Emslie ◽

Apurva Prakash ◽

Qi Zhang ◽

Beth A. Pangallo ◽

Mark E. Bangs ◽

...

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Children And Adolescents ◽

Efficacy And Safety ◽

Major Depressive ◽

Safety Study ◽

Double Blind

Download Full-text

A Double-Blind Efficacy and Safety Study of Duloxetine Flexible Dosing in Children and Adolescents with Major Depressive Disorder

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2013.0146 ◽

2014 ◽

Vol 24 (4) ◽

pp. 180-189 ◽

Cited By ~ 37

Author(s):

Sarah D. Atkinson ◽

Apurva Prakash ◽

Qi Zhang ◽

Beth A. Pangallo ◽

Mark E. Bangs ◽

...

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Children And Adolescents ◽

Efficacy And Safety ◽

Major Depressive ◽

Safety Study ◽

Double Blind ◽

Flexible Dosing

Download Full-text

Statement of Retraction: Efficacy and safety of vortioxetine for the treatment of major depressive disorder: a randomised double-blind placebo-controlled study

International Journal of Psychiatry in Clinical Practice ◽

10.1080/13651501.2021.1950437 ◽

2021 ◽

pp. 1-1

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Controlled Study ◽

Efficacy And Safety ◽

Major Depressive ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Efficacy and safety of moclobemide compared with imipramine in the treatment of major depressive disorder. Double-blind Multicenter Study, Austria

Amine Oxidases and Their Impact on Neurobiology ◽

10.1007/978-3-7091-9113-2_26 ◽

1990 ◽

pp. 177-184 ◽

Cited By ~ 1

Author(s):

G. F. Hebenstreit ◽

M. Loidl ◽

U. Baumhackl ◽

B. Gallhofer ◽

Ch. Geretsegger ◽

...

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Multicenter Study ◽

Efficacy And Safety ◽

Major Depressive ◽

Double Blind

Download Full-text

A randomized, double-blind study comparing the efficacy and safety of trazodone once-a-day and venlafaxine extended-release for the treatment of patients with major depressive disorder

International Clinical Psychopharmacology ◽

10.1097/yic.0000000000000304 ◽

2020 ◽

Vol 35 (3) ◽

pp. 137-146 ◽

Cited By ~ 3

Author(s):

Andrea Fagiolini ◽

Umberto Albert ◽

Laura Ferrando ◽

Erik Herman ◽

Cosmina Muntean ◽

...

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Extended Release ◽

Blind Study ◽

Double Blind Study ◽

Efficacy And Safety ◽

Major Depressive ◽

Double Blind

Download Full-text

Efficacy and safety of vortioxetine for the treatment of major depressive disorder: a randomised double-blind placebo-controlled study

International Journal of Psychiatry in Clinical Practice ◽

10.1080/13651501.2017.1397700 ◽

2017 ◽

Vol 23 (4) ◽

pp. 245-250 ◽

Cited By ~ 2

Author(s):

Jing Wang ◽

Xi-Fang Liu ◽

Chong Feng ◽

Quan Bao ◽

Hong-Ran Fu

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Controlled Study ◽

Efficacy And Safety ◽

Major Depressive ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Clinical Trial Protocol: Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, and Safety Study Comparing EG-1962 to Standard of Care Oral Nimodipine in Adults with Aneurysmal Subarachnoid Hemorrhage [NEWTON-2 (Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After SubarachNoid Hemorrhage)]

Neurocritical Care ◽

10.1007/s12028-018-0575-z ◽

2018 ◽

Vol 30 (1) ◽

pp. 88-97 ◽

Cited By ~ 17

Author(s):

Daniel Hänggi ◽

◽

Nima Etminan ◽

Stephan A. Mayer ◽

E. Francois Aldrich ◽

...

Keyword(s):

Subarachnoid Hemorrhage ◽

Aneurysmal Subarachnoid Hemorrhage ◽

Standard Of Care ◽

Efficacy And Safety ◽

Safety Study ◽

Phase 3 ◽

Double Blind ◽

Group Efficacy ◽

Double Blind Placebo ◽

Parallel Group

Download Full-text

Switching to Reboxetine: An Efficacy and Safety Study in Patients With Major Depressive Disorder Unresponsive to Fluoxetine

Journal of Clinical Psychopharmacology ◽

10.1097/01.jcp.0000085409.08426.4c ◽

2003 ◽

Vol 23 (4) ◽

pp. 365-369 ◽

Cited By ~ 23

Author(s):

Maurizio Fava ◽

Patrick J. McGrath ◽

Wang-Pui Sheu

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Efficacy And Safety ◽

Major Depressive ◽

Safety Study

Download Full-text

A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder

International Clinical Psychopharmacology ◽

10.1097/yic.0b013e3283542457 ◽

2012 ◽

Vol 27 (4) ◽

pp. 215-223 ◽

Cited By ~ 233

Author(s):

Cornelius Katona ◽

Thomas Hansen ◽

Christina Kurre Olsen

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Elderly Patients ◽

Fixed Dose ◽

Efficacy And Safety ◽

Major Depressive ◽

Double Blind ◽

Double Blind Placebo ◽

Dose Study

Download Full-text

Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial

Yearbook of Psychiatry and Applied Mental Health ◽

10.1016/s0084-3970(08)79213-2 ◽

2009 ◽

Vol 2009 ◽

pp. 281-282

Author(s):

J.C. Ballenger

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Fixed Dose ◽

Efficacy And Safety ◽

Major Depressive ◽

Double Blind ◽

Double Blind Placebo ◽

Dose Trial

Download Full-text